Reply to "Albumin infusion in cirrhotic patients with non-SBP infections: End of the story?"

J Hepatol. 2015 Sep;63(3):768-9. doi: 10.1016/j.jhep.2015.05.007. Epub 2015 May 18.

Authors

Thierry Thevenot¹, Elisabeth Monnet², Vincent di Martino²; ALB-CIRINF Study Group

Collaborators

ALB-CIRINF Study Group:
P Assor, C Barrault, S Bellati, H Benosman, B Bernard-Chabert, J Boursier, J P Bronowicki, P Cales, J P Cervoni, C Christol, L Costes, S Dalle, T Davion, L Delique, M L Dreher, S Dritsas, B Dupont, F Ehrhard, I Fouchard-Hubert, T Gérard, H Hagege, P Hillon, P Mathurin, H Montialoux, R Moreau, I Ollivier, J M Péron, G Riachi, C Richou, M A Robic, A Techy, I Touze, A Tran, C Vanlemmens, J P Vinel

Affiliations

¹ Service d'Hépatologie et de Soins Intensifs Digestifs, Centre Hospitalier Universitaire Jean Minjoz, 25030 Besançon cedex, France. Electronic address: [email protected].
² Service d'Hépatologie et de Soins Intensifs Digestifs, Centre Hospitalier Universitaire Jean Minjoz, 25030 Besançon cedex, France.

PMID: 25998162
DOI: 10.1016/j.jhep.2015.05.007

No abstract available

Publication types

Letter
Comment

MeSH terms

Albumins / administration & dosage*
Anti-Bacterial Agents / administration & dosage*
Bacterial Infections*
Female
Humans
Liver Cirrhosis / complications*
Male
Renal Insufficiency*
Sepsis*

Substances

Albumins
Anti-Bacterial Agents